104 related articles for article (PubMed ID: 1868885)
1. Characterization of the major matrix degrading metalloproteinase of human corneal stroma. Evidence for an enzyme/inhibitor complex.
Brown D; Chwa M; Escobar M; Kenney MC
Exp Eye Res; 1991 Jan; 52(1):5-16. PubMed ID: 1868885
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
Girard MT; Matsubara M; Fini ME
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
[TBL] [Abstract][Full Text] [Related]
3. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
4. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
5. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
7. Studies on purified neutral proteoglycan-degrading enzyme (stromelysin/matrix metalloproteinase 3) from human articular cartilage.
Gunja-Smith Z; Nagase H; Woessner JF
Matrix Suppl; 1992; 1():82-3. PubMed ID: 1480097
[No Abstract] [Full Text] [Related]
8. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1).
Opbroek A; Kenney MC; Brown D
Curr Eye Res; 1993 Oct; 12(10):877-83. PubMed ID: 7507419
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
10. Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells.
Yasumitsu H; Miyazaki K; Umenishi F; Koshikawa N; Umeda M
J Biochem; 1992 Jan; 111(1):74-80. PubMed ID: 1318881
[TBL] [Abstract][Full Text] [Related]
11. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
12. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
Rice A; Banda MJ
Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
[TBL] [Abstract][Full Text] [Related]
14. Unique regulation of the matrix metalloproteinase, gelatinase B.
Fini ME; Girard MT; Matsubara M; Bartlett JD
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):622-33. PubMed ID: 7890493
[TBL] [Abstract][Full Text] [Related]
15. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Rifas L; Fausto A; Scott MJ; Avioli LV; Welgus HG
Endocrinology; 1994 Jan; 134(1):213-21. PubMed ID: 8275936
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
17. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors.
Brown D; Chwa MM; Opbroek A; Kenney MC
Curr Eye Res; 1993 Jun; 12(6):571-81. PubMed ID: 8359032
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of a gelatinase A activity in keratoconus.
Smith VA; Hoh HB; Littleton M; Easty DL
Eye (Lond); 1995; 9 ( Pt 4)():429-33. PubMed ID: 7498560
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
Crabbe T; Kelly SM; Price NC
FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation.
Trancart MM; Chalmeigne N; Girardot C; Zarpanelian C; Prigent D
Int J Tissue React; 1992; 14(6):287-94. PubMed ID: 1339118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
